Provided by Tiger Trade Technology Pte. Ltd.

Chemed

505.97
-3.9400-0.77%
Post-market: 505.970.00000.00%19:30 EDT
Volume:144.67K
Turnover:73.26M
Market Cap:6.59B
PE:25.45
High:516.88
Open:509.06
Low:500.52
Close:509.91
52wk High:557.00
52wk Low:365.21
Shares:13.02M
Float Shares:11.85M
Volume Ratio:1.17
T/O Rate:1.22%
Dividend:2.40
Dividend Rate:0.47%
EPS(TTM):19.88
EPS(LYR):18.34
ROE:27.11%
ROA:13.45%
PB:7.93
PE(LYR):27.59

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Veracyte (VCYT), IQVIA Holdings (IQV) and Chemed (CHE)

TIPRANKS
·
Yesterday

Chemed Unit Buys Franchise Territory in California

MT Newswires Live
·
Yesterday

Chemed Corporation -Unit Roto-Rooter Buys Largest Franchise for $60.60 Mln

THOMSON REUTERS
·
Yesterday

Press Release: Roto-Rooter Buys Largest Franchisee Territory

Dow Jones
·
Yesterday

Chemed to Present at Jefferies Healthcare Services and Technology Conference

Reuters
·
Sep 08

Chemed (CHE) Dropped, What Is Behind The Fresh Attention?

Simply Wall St.
·
Aug 29

Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says

TIPRANKS
·
Aug 28

Chemed CEO Kevin McNamara Sells 2,000 Shares for $1.08 Million

Reuters
·
Aug 24

Did Chemed's (CHE) Dividend Hike and Earnings Beat Just Shift Its Capital Allocation Narrative?

Simply Wall St.
·
Aug 10

Chemed Raises Quarterly Dividend to $0.70 a Share, Payable Sept. 3 to Shareholders of Record Aug. 17

MT Newswires Live
·
Aug 07

Chemed boosts quarterly dividend to 70c from 60c per share

TIPRANKS
·
Aug 07

Chemed Declares Quarterly Dividend of 70 Cents a Share

Reuters
·
Aug 06

Top Executive’s Major Move Sends Chemed Investors Scrambling for Answers

TIPRANKS
·
Aug 05

Insider Shake-Up: Chemed Director’s Stock Move Sparks Investor Buzz

TIPRANKS
·
Aug 04

Chemed Director Patrick P. Grace Sells 190 Shares for $101,080

Reuters
·
Aug 04

Chemed’s VITAS Drives Upbeat Earnings Call

TIPRANKS
·
Aug 03

Chemed price target raised to $590 from $500 at Oppenheimer

TIPRANKS
·
Jul 31

Chemed price target raised to $548 from $436 at RBC Capital

TIPRANKS
·
Jul 30

RBC Raises Price Target on Chemed to $548 From $436, Keeps Sector Perform Rating

MT Newswires Live
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30